Trade Avidity Biosciences Inc - RNA CFD

Add to favourite

29.70

11.4%

0.13

Low: 26.34

High: 30.43

Market Trading Hours* (UTC) Opens on Thursday at 13:30

Mon - Fri: 13:30 - 20:00

Summary
Historical Data

Trading сonditions

Spread

0.13

Long position overnight fee

-0.023624%

Short position overnight fee

0.001401%

Overnight fee time

21:00 (UTC)

Min traded quantity

Currency

USD

Margin

50.00%

Stock exchange

United States of America

Commission on trade

Key Stats

Prev. Close	26.66
Open	26.34
1-Year Change	84.45%
Day's Range	26.34 - 30.43

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Apr 1, 2025	26.66	-2.56	-8.76%	29.22	29.22	26.48
Mar 31, 2025	29.45	-0.51	-1.70%	29.96	30.05	28.44
Mar 28, 2025	31.55	-0.50	-1.56%	32.05	32.30	31.07
Mar 27, 2025	32.44	0.69	2.17%	31.75	33.04	31.75
Mar 26, 2025	31.99	0.26	0.82%	31.73	32.50	31.66
Mar 25, 2025	32.04	-0.17	-0.53%	32.21	32.85	31.67
Mar 24, 2025	33.22	2.27	7.33%	30.95	33.72	30.87
Mar 21, 2025	30.77	0.46	1.52%	30.31	31.13	30.07
Mar 20, 2025	30.79	0.21	0.69%	30.58	32.13	30.58
Mar 19, 2025	31.66	1.38	4.56%	30.28	31.78	30.28
Mar 18, 2025	30.41	-2.79	-8.40%	33.20	33.21	30.39
Mar 17, 2025	33.78	2.88	9.32%	30.90	33.88	30.08
Mar 14, 2025	31.05	-1.28	-3.96%	32.33	32.82	30.79
Mar 13, 2025	32.07	-0.88	-2.67%	32.95	36.21	32.02
Mar 12, 2025	32.55	2.54	8.46%	30.01	32.63	30.01
Mar 11, 2025	29.52	-0.48	-1.60%	30.00	30.41	28.86
Mar 10, 2025	29.95	1.08	3.74%	28.87	30.64	28.87
Mar 7, 2025	30.24	0.38	1.27%	29.86	30.84	28.97
Mar 6, 2025	30.29	1.66	5.80%	28.63	30.74	28.63
Mar 5, 2025	29.50	0.88	3.07%	28.62	30.22	28.58

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

Leverage

2:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Avidity Biosciences Inc

Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company''s lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease; and to design, engineer, and develop therapeutics that combine tissue selectivity of monoclonal antibodies and the precision of oligonucleotide therapies to access previously undruggable tissue and cell types, and target underlying genetic drivers of diseases. In addition, it develops muscle programs, which focuses on the treatment of facioscapulohumeral muscular dystrophy, Duchenne muscular dystrophy, muscle atrophy, and Pompe diseases. Avidity Biosciences, Inc. was incorporated in 2012 and is based in La Jolla, California.